Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis
HomePublicationsEvolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis
Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis
2016 GRHTA
Ruggeri, M. | Aiello, A. | D’Ausilio, A. | Di Brino, E. | Cottone, S. | Ghezzi, A. | Lombardozzi, L. | Mecozzi, A. | Sacchini, D. | Roccia, A. | Mangone, M. | Toumi, M. |
Volume: 3,
Issue: 3,
Pages: 125–133,
